Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Ipatasertib dihydrochloride | 1396257-94-5 | C24H34Cl3N5O2 | 1 G
SDP

Catalog No. 5000374856
Encompass_Preferred

Ipatasertib dihydrochloride is a highly selective and ATP-competitive pan-Akt inhibitor, demonstrating significant selectivity against Akt1, Akt2, and Akt3. It is intended for research use only.

  • Highly selective and ATP-competitive pan-Akt inhibitor
  • IC50s of 5, 18, and 8 nM for Akt1, Akt2, and Akt3, respectively
  • Exhibits over 600-fold and over 100-fold selectivity for Akt1 against PKA and p70S6K
  • Effective in xenograft models with Akt activation
  • Achieves tumor growth delay, stasis, or regression in vivo

Catalog No. 50-003-74856 Supplier Medchemexpress LLC Supplier No. HY15186A1G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ipatasertib dihydrochloride is a highly selective and ATP-competitive pan-Akt inhibitor, demonstrating significant selectivity against Akt1, Akt2, and Akt3. It is intended for research use only.

  • Highly selective and ATP-competitive pan-Akt inhibitor
  • IC50s of 5, 18, and 8 nM for Akt1, Akt2, and Akt3, respectively
  • Exhibits over 600-fold and over 100-fold selectivity for Akt1 against PKA and p70S6K
  • Effective in xenograft models with Akt activation
  • Achieves tumor growth delay, stasis, or regression in vivo

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.